How common chemo drug thwarts graft rejection in bone marrow transplants
Thursday, November 14, 2013 - 14:01
in Health & Medicine
Results of a study may explain why a chemotherapy drug called cyclophosphamide prevents graft-versus-host (GVHD) disease in people who receive bone marrow transplants. The experiments point to an immune system cell that evades the toxic effects of cyclophosphamide and protects patients from a lethal form of GVHD.